Table 1.
Only SNPs with MAF of 0.01 or above is included | |||||
---|---|---|---|---|---|
Epistasis | WMI Bonferoni corrected | ||||
Subpopulation | Subjects | Valid SNPs | Number | Total WMI | Number |
2 | 44 | 140 | 8197 | 244 | 34 |
3 | 143 | 68 | 1734 | 3 | 9 |
4 | 16 | 121 | 5058 | 318 | 16 |
5 | 53 | 125 | 6360 | 281 | 39 |
6 | 82 | 137 | 7411 | 224 | 43 |
7 | 85 | 135 | 6774 | 264 | 34 |
8 | 12 | 110 | 516 | 173 | 4 |
9 | 83 | 130 | 6483 | 265 | 40 |
10 | 23 | 124 | 6987 | 318 | 18 |
11 | 90 | 126 | 5724 | 257 | 41 |
12 | 14 | 113 | 5914 | 470 | 14 |
13 | 61 | 123 | 5915 | 288 | 43 |
14 | 16 | 117 | 3818 | 414 | 9 |
722 | 70,891 | 3521 | 344 | ||
Fraction of possible epistasis | 42.60% | ||||
WMI/epistasis ratio | 0.49% | ||||
Unique WMI-significant interactions | 185 | 53.78% | |||
Males | 1258 | 100 | 2911 | 8.70 | 16 |
Females | 1251 | 69 | 1539 | 2.28 | 6 |
2509 | 4450 | 10.97 | 22 | ||
WMI/epistasis ratio | 0.49% |